B G Gazzard

3.5k total citations · 1 hit paper
59 papers, 2.4k citations indexed

About

B G Gazzard is a scholar working on Epidemiology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, B G Gazzard has authored 59 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 13 papers in Infectious Diseases and 13 papers in Emergency Medicine. Recurrent topics in B G Gazzard's work include Drug-Induced Hepatotoxicity and Protection (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers) and HIV/AIDS drug development and treatment (8 papers). B G Gazzard is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers) and HIV/AIDS drug development and treatment (8 papers). B G Gazzard collaborates with scholars based in United Kingdom, United States and India. B G Gazzard's co-authors include Bernard Portmann, Roger Williams, Robert J. Williams, Joseph M. Henderson, Roger Williams, J D Cartledge, Roger Williams, Vicente Arroyo, S P Wilkinson and Helen Moodie and has published in prestigious journals such as The Lancet, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

B G Gazzard

59 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008

2008 667 citations B G Gazzard et al. HIV Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B G Gazzard United Kingdom	25	933	703	585	556	386	59	2.4k
Mario Regazzi Italy	36	869 0.9×	631 0.9×	148 0.3×	415 0.7×	223 0.6×	136	3.6k
Stefano Bonora Italy	34	2.5k 2.6×	962 1.4×	415 0.7×	1.3k 2.4×	170 0.4×	223	3.8k
Thomas Marbury United States	41	959 1.0×	1.4k 2.0×	794 1.4×	300 0.5×	270 0.7×	217	5.9k
Rolf P. G. van Heeswijk Netherlands	24	1.9k 2.0×	846 1.2×	217 0.4×	750 1.3×	146 0.4×	41	2.3k
Hartwig Klinker Germany	31	1.1k 1.2×	1.6k 2.3×	1.3k 2.2×	472 0.8×	106 0.3×	157	2.9k
John G. Gambertoglio United States	31	565 0.6×	648 0.9×	100 0.2×	279 0.5×	210 0.5×	91	2.4k
Anita Mathias United States	27	1.4k 1.5×	708 1.0×	700 1.2×	389 0.7×	344 0.9×	65	2.6k
Edward O’Mara United States	21	668 0.7×	505 0.7×	247 0.4×	149 0.3×	369 1.0×	46	1.6k
Vincent Jullien France	31	1.1k 1.2×	736 1.0×	98 0.2×	301 0.5×	238 0.6×	125	3.3k
Anne‐Marie Taburet France	26	1.5k 1.6×	406 0.6×	137 0.2×	818 1.5×	180 0.5×	74	2.1k

Countries citing papers authored by B G Gazzard

Since Specialization

Citations

This map shows the geographic impact of B G Gazzard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B G Gazzard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B G Gazzard more than expected).

Fields of papers citing papers by B G Gazzard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B G Gazzard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B G Gazzard. The network helps show where B G Gazzard may publish in the future.

Co-authorship network of co-authors of B G Gazzard

This figure shows the co-authorship network connecting the top 25 collaborators of B G Gazzard. A scholar is included among the top collaborators of B G Gazzard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B G Gazzard. B G Gazzard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jackson, Akil, Laura Else, Pedro M. M. Mesquita, et al.. (2014). A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis. Clinical Pharmacology & Therapeutics. 96(3). 314–323. 89 indexed citations

Gazzard, B G, et al.. (2008). British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008. HIV Medicine. 9(8). 563–608. 667 indexed citations breakdown →

Martin, Jackie L., et al.. (2004). Hypokalaemia in ibuprofen and codeine phosphate abuse. International Journal of Clinical Practice. 58(11). 1061–1062. 38 indexed citations

Allen, Samuel H., Miranda Nelson, David Asboe, et al.. (2003). Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART era. Postgraduate Medical Journal. 79(938). 691–694. 10 indexed citations

Midgley, J, et al.. (1999). A RANDOMISED, DOUBLE‐BLIND STUDY OF ITRACONAZOLE VERSUS PLACEBO IN THE TREATMENT AND PREVENTION OF ORAL OR OESOPHAGEAL CANDIDOSIS IN PATIENTS WITH HIV INFECTION. International Journal of Clinical Practice. 53(5). 349–352. 15 indexed citations

Cartledge, J D, J Midgley, Michael A. Petrou, D.C. Shanson, & B G Gazzard. (1997). Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests. Journal of Antimicrobial Chemotherapy. 40(4). 517–523. 20 indexed citations

Moyle, Graeme & B G Gazzard. (1997). Surrogate markers now provide physicians with the best means to manage antiretroviral therapy: The case for. Sexually Transmitted Infections. 73(3). 216–218. 2 indexed citations

Guiloff, R J, et al.. (1996). Aids-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNFα). Journal of the Neurological Sciences. 138(1-2). 134–144. 14 indexed citations

Forbes, Alastair, C Blanshard, & B G Gazzard. (1993). Natural history of AIDS related sclerosing cholangitis: a study of 20 cases.. Gut. 34(1). 116–121. 78 indexed citations

10.

Gazzard, B G. (1992). Diarrhea in Human Immunodeficiency Virus Antibody-Positive Patients. Seminars in Liver Disease. 12(2). 154–166. 19 indexed citations

11.

Fuller, Geraint, et al.. (1988). Occult AIDS: pneumocystis carinii pneumonia in elderly people.. BMJ. 297(6650). 721–722. 8 indexed citations

12.

Theodossi, A, et al.. (1982). Attempted immune stimulation in the "gay compromise syndrome".. BMJ. 285(6348). 1082–1082. 12 indexed citations

13.

Gazzard, B G, et al.. (1976). Why do people use paracetamol for suicide?. BMJ. 1(6003). 212–213. 28 indexed citations

14.

Murray-Lyon, I M, A. HILARY ORR, B G Gazzard, J. Kohn, & Roger D. Williams. (1976). Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion.. Gut. 17(8). 576–580. 29 indexed citations

15.

Gazzard, B G, Joseph M. Henderson, & Robert J. Williams. (1975). The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsy.. Gut. 16(8). 621–625. 29 indexed citations

16.

Gazzard, B G, et al.. (1975). Causes of Death in Fulminant Hepatic Failure and Relationship to Quantitative Histological Assessment of Parenchymal Damage. QJM. 44(176). 615–26. 146 indexed citations

17.

Weston, M.J., P. J. Mellon, P.G. Langley, et al.. (1975). Resin Column Perfusion with Whole Blood or Plasma Separated by the Continuous Flow Celltrifuge. Clinical Science. 48(3). 187–192. 5 indexed citations

18.

Gazzard, B G, Russ Clark, P.T. Flute, & Roger Williams. (1975). Factor VIII levels during the course of acute hepatitis in a haemophiliac.. Journal of Clinical Pathology. 28(12). 972–974. 2 indexed citations

19.

Gazzard, B G, et al.. (1974). A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis. Gut. 15(2). 89–93. 36 indexed citations

20.

Gazzard, B G, et al.. (1974). Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure. Gut. 15(12). 993–998. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact